Motivational Approach to Treat Childhood Obesity

NCT03749200 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 319

Last updated 2024-06-03

No results posted yet for this study

Summary

The treatment of childhood obesity is challenging. Although dietary and physical activity recommendations are widely known, the willingness to change lifestyles within the family is not easy to be achieved. Motivational interviewing has been shown as a possibly effective method to increase adherence to dietary recommendations in the obese adult.

There is scarce evidence showing whether implementing a motivational interview in obese children could be effective.

The aim of this clinical trial is assessing the effect of a motivational interview, coordinated between the clinical and primary care services on 8 to 14 years old obese children.

Conditions

  • Childhood Obesity
  • Metabolic Syndrome
  • Body Composition

Interventions

OTHER

Obemat2.0 therapy

OTHER

Regular practise in primary care

Sponsors & Collaborators

  • Institut Català de la Salut

    collaborator OTHER
  • Hospital Universitari Joan XXIII de Tarragona.

    collaborator OTHER
  • Hospital Universitari Sant Joan de Reus

    collaborator OTHER
  • Instituto de Salud Carlos III

    collaborator OTHER_GOV
  • Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina

    collaborator OTHER
  • University Rovira i Virgili

    collaborator OTHER
  • Institut Investigacio Sanitaria Pere Virgili

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
8 Years
Max Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2020-12-30
Completion
2021-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03749200 on ClinicalTrials.gov